Real-World Impact of Differences in the Who and ICC Classifications of Non-Hodgkin Lymphoma: A Leo Cohort Study Analysis

Authors

Brooj Abro
Matthew J Maurer
Thomas M Habermann
W Richard Burack
Jennifer R Chapman
Jonathon B Cohen
Jonathan W Friedberg
Giorgio Inghirami
Brad S Kahl
Melissa C Larson
Brian K Link
Izidore S Lossos
Peter Martin
Timothy J McDonnell
Loretta J Nastoupil
Shaun M Riska
Sergei Syrbu
Francisco Vega
Kiran R Vij
Christopher R Flowers
James R Cerhan
David L Jaye
Andrew L Feldman

Language

English

Publication Date

11-7-2024

Journal

Blood

DOI

10.1182/blood.2024025681

PMID

39255410

PMCID

PMC11561535

PubMedCentral® Posted Date

9-12-2024

PubMedCentral® Full Text Version

Post-print

Abstract

Recent introduction of 2 different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that differences between the classifications will affect < 1% of non-Hodgkin lymphomas.

Keywords

Humans, Lymphoma, Non-Hodgkin, Cohort Studies, Male, Female, Middle Aged, World Health Organization, Aged, Adult, Aged, 80 and over

Published Open-Access

yes

Recommended Citation

Abro, Brooj; Maurer, Matthew J; Habermann, Thomas M; et al., "Real-World Impact of Differences in the Who and ICC Classifications of Non-Hodgkin Lymphoma: A Leo Cohort Study Analysis" (2024). Faculty, Staff and Student Publications. 6260.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/6260